Safety and Tolerability Comparison of Immediate and Controlled Release Formulations of Ecopipam
Clinical trial NCT01408394 · COMPLETED
Trial details
- NCT number
- NCT01408394
- Sponsor
- Emalex Biosciences Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-08-01
- Primary completion
- 2012-02-01
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.